BSECompany UpdateM&A4d ago
Krishna Institute of Medical Sciences Ltd
Intimation of Merger of Wholly owned subsidiary i.e KHPL with its holding company i.e Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Ltd has announced the merger of its wholly-owned subsidiary, KIMS Hospitals Private Limited, with the company under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
BSECompany UpdateResults4d ago
Parag Milk Foods Ltd
Parag Milk Foods Limited has informed Exchange about audio recordings of Earnings Call under Regulation 30 of the SEBI (LODR) Regulations.
Parag Milk Foods Ltd has informed the exchange about the availability of the audio recording of its earnings conference call for the quarter and half year ended September 30, 2026, on its website.
BSECompany UpdateResults4d ago
Zim Laboratories Ltd
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed the Earnings Presentation for Q2 & H1 FY27.
Zim Laboratories Ltd has released its earnings presentation for Q2 & H1 FY27, showing an 18.9% increase in total operating income and a 7.3% EBITDA margin.
BSEBoard MeetingResults4d ago
Vindhya Telelinks Ltd
Submission of Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half year ended on 30th September, 2026.
Vindhya Telelinks Ltd has submitted its unaudited standalone and consolidated financial results for the quarter and half year ended on 30th September, 2026, showing a profit of ₹5781.42 lakhs and ₹8591.39 lakhs respectively.
BSEBoard MeetingResults4d ago
Shukra Pharmaceuticals Ltd
Unaudited financial results for the quarter ended 30th September 2026
Shukra Pharmaceuticals Ltd has announced unaudited financial results for the quarter ended 30th September 2026, with a net profit of ₹1,601.20 lakhs and revenue from operations of ₹4,477.58 lakhs.
BSEBoard MeetingResults4d ago
Gujjubhai Industries Ltd
With reference to the captioned subject and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 and other applicable provisions of the SEBI Listing Regulations, this is to inform you that, the Board of Directors of the Company, at its meeting held on Wednesday, November 04, 2026 have, inter alia, considered and approved the following:
1. Pursuant to Regulation 33 and Regulation 30 read with ....
Gujjubhai Industries Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a net profit of ₹315.37 lakhs and ₹209.98 lakhs respectively. The company's revenue from operations for the quarter ended September 30, 2026, was ₹6,000.00 lakhs.
BSECompany UpdateAuditor Change4d ago
Sadbhav Engineering Ltd
Please find enclosed intimation of resignation of statutory auditor of the company w.e.f. close of business hours on November 04, 2026.
Sadbhav Engineering Ltd has announced the resignation of its statutory auditor, M/s. Manubhai & Shah LLP, effective November 4, 2026, due to significant reduction in the company's operational activities.
BSECompany UpdateResults4d ago
Steelco Gujarat Ltd
Statement of Deviation or Variation for the quarter ended September 30, 2026 for Rights Issue Proceeds is enclosed.
Steelco Gujarat Ltd has submitted a statement of deviation or variation for the quarter ended September 30, 2026, for the utilization of rights issue proceeds, confirming no deviations or variations in the utilization of the net proceeds.
BSECompany UpdateMgmt Change4d ago
Aurobindo Pharma Ltd
Reappointment of Mr. M. R. Kumar as Independent Director of the Company for second term with effect from April 1, 2027.
Aurobindo Pharma Ltd has announced the reappointment of Mr. M. R. Kumar as Independent Director for a second term of five years, effective April 1, 2027.
BSECorp. ActionDividend4d ago
Galaxy Surfactants Ltd
Corporate Action- Board approved Interim Dividend
Galaxy Surfactants Ltd has announced its board meeting outcome, approving interim dividend of Rs.18 per equity share, re-appointment of MD, change in Company Secretary and Compliance Officer, and appointment of Statutory Auditors.
BSECompany UpdateResults4d ago
Mold-Tek Technologies Ltd
Audio Recording of Earnings Conference Call held on November 04, 2026 at 04:30 PM IST
Mold-Tek Technologies Ltd has uploaded the audio recording of its earnings conference call held on November 4, 2026, to discuss Q2FY27 results on its website.
BSECompany UpdateMgmt Change4d ago
Wardwizard Foods and Beverages Ltd
Intimation Under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Appointment of Additional Non-Executive Independent Directors
Wardwizard Foods and Beverages Ltd has appointed two additional non-executive independent directors, Mr. Bhavin Rajubhai Patel and Mr. Vishal Manharbhai Shah, for a period of five consecutive years, subject to shareholder approval.
BSECompany UpdateResults4d ago
Shree Pushkar Chemicals & Fertilisers Ltd
Please find attached herewith
Shree Pushkar Chemicals & Fertilisers Ltd has published its unaudited standalone and consolidated financial results for the second quarter and half year ended 30th September, 2026, in newspapers as per Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
BSECompany UpdateResults4d ago
Kirloskar Oil Engines Ltd
Please find attached herewith Investor Presentation.
Kirloskar Oil Engines Ltd has announced the upload of its un-audited financial results for Q2 FY27 on its website, along with an investor presentation for a conference call scheduled on November 5, 2026.
BSECompany UpdateM&A4d ago
Aurobindo Pharma Ltd
Transfer of ownership of Auro Pharma LLC, Russia from Auroactive Pharma Private Limited to Auropharm Overseas Limited, Wholly Owned subsidiaries of the Company.
Aurobindo Pharma Ltd has announced the transfer of ownership of Auro Pharma LLC, Russia from Auroactive Pharma Private Limited to Auropharm Overseas Limited, a wholly owned subsidiary of the Company. The transaction is exempt from SEBI regulations due to being between two wholly owned subsidiaries.
BSECompany UpdateMgmt Change4d ago
Krishna Institute of Medical Sciences Ltd
Reappointment of Dr. Abhinay Bollineni, Dr. Bhaskara Rao Bollineni and Ms. Dandamudi Anitha
Krishna Institute of Medical Sciences Ltd has announced the reappointment of Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as Chairman & Managing Director, and Ms. Dandamudi Anitha as Whole-time Director for a further term of 5 years.
BSEResultResults4d ago
Galaxy Surfactants Ltd
Please find attached Unaudited Financial Results (Consolidated and Standalone) for quarter and half year ended on September 30, 2026
Galaxy Surfactants Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with the board approving an interim dividend of Rs.18/- per equity share. The company has also re-appointed Mr. K. Natarajan as Managing Director and appointed Ms. Roopali Vikram Kamate as Company Secretary and Compliance Officer. Additionally, the board has approved the appointment of M/s. S R B C & CO LLP as the Statutory Auditors of the Company.
BSEResultResults4d ago
All Time Plastics Ltd
Unaudited Financial Results
All Time Plastics Ltd has announced unaudited financial results for the quarter and half year ended September 30, 2026, along with the Limited Review Report issued by the Statutory Auditors. The company has also approved the transfer of Mr. Rahul Vohra, General Manager, from All Time Plastics Limited to All Time Bamboo Private Limited, a Wholly Owned Subsidiary company, and further investment of ₹5,00,00,000/- in All Time Bamboo Private Limited.
BSECompany UpdateRegulatory4d ago
Transchem Ltd-$
Please refer the attached Monitoring Agency Report for the quarter ended September 30, 2026.
Transchem Ltd has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, as per Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report was issued by Acuite Ratings & Research Limited and reviewed by the Audit Committee and Board of Directors.
BSEBoard MeetingResults4d ago
NRB Bearings Ltd
Outcome of Board Meeting held on November 04, 2026
NRB Bearings Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, along with a limited review report. The board has also declared an interim dividend of Rs. 2.50 per equity share, fixed November 11, 2026, as the record date. Additionally, Mr. Rustom Desai will complete his tenure as an independent director on January 22, 2027, and the company has reconstituted its Nomination and Remuneration Committee.